key: cord-0745510-9ldsnsko
authors: Leventelis, C.; Katsouli, A.; Papadopoulos, P.; Stauropoulos, V.; Karasavidou, A.; Batsiari, E.; Tsironi, M.
title: P.0615 Biopsychosocial effect of the Covid-19 pandemic in patients under medication-assisted treatment with methadone and buprenorphine
date: 2021-12-30
journal: Eur Neuropsychopharmacol
DOI: 10.1016/j.euroneuro.2021.10.580
sha: 4fd50ed4649ca1f36a0a89354216c420cad79cdb
doc_id: 745510
cord_uid: 9ldsnsko

Introduction: The Covid-19 pandemic is a global threat to public health, mainly affecting vulnerable groups, such as the elderly, chronically ill patients, or patients with substance use disorders (SUD) [1]. Prolonged use results in neurobiological changes in the cerebral area, activating the "reward system," leading to development of drug-seeking behaviors and upregulating proinflammatory cytokines, as well as growth factors [2,3]. The immune system's response inducing Covid-19 virus even to moderate symptoms by adapting the immunomodulation, seems to lead to an inflammatory process, especially in patients with pre-existing production of inflammatory agents, such as patients with SUD [4]. Objective: The investigation of biopsychosocial responses of the Covid-19 pandemic in patients under medication-assisted treatment (MAT) with methadone and buprenorphine and their correlation to biological factors. Material and Methods: 64 patients with Covid-19 were included in the study sample, 26 (40.6%) under methadone administration and 38 (59.4%) under buprenorphine ones. The Control group consisted of patients with SUD that had not been infected by the virus and Covid-19 patients without previous history of substance use. Blood samples were obtained in both groups to determine C-reactive protein (CRP), cortisol, IFNa1, IFNa2, IFNγ, IL-1a, IL-1β, IL-5, IL-6, IL-8, IL-10, IL-18, MCP-1, TNF-a, but in patients with Covid-19, blood samples were obtained at the first, seventh and sixteenth day after infection. The sample with SUD had completed a structured questionnaire (Medication-Assisted Treatment Questionnaire Covid-19 – MATQ/Covid-19) about Covid-19 effect in terms of medications’ administration (methadone and buprenorphine) and psychosocial life. Statistical significance was ascertained by t-tests, ANOVA and Pearson's x2 test as appropriate. Results: Reduced management of medications at take-home doses (p<0.05) and physical dysfunctions (p<0.05) were observed in both groups with SUD. Regarding the patients under methadone treatment, social isolation (p<0.05) and the need for psychosocial support from the therapeutic programs (p<0.001) were found increased. According to the results, the values of cortisol, IL-1a, IL-1b, IL-8 and MCP-1 were significantly elevated (p<0.05) in the study sample compared to the control group. Furthermore, biological factors on the 7th and 16th day after Covid-19 infection (cortisol, IL-1b, IL-8, TNF-a, MCP-1, IL-6) in methadone administration were significantly increased (p<0.05) while greater values of CRP (p<0.05) on the first and seventh day were observed in the buprenorphine group. In respect of the findings, the IL-8 and MCP-1 were significantly increased in the methadone group compared to the buprenorphine group. Moreover, increased values of IL-8 and MCP-1 positively were correlated with the need for psychosocial support, drug-seeking behavior and relapse. Conclusions: In conclusion, the Covid-19 virus negatively influences the immune system in patients under substitution treatment. Although methadone and buprenorphine are key substances as MAT, they seem able to exacerbate the dysregulated cellular functions due to the Covid-19 virus and, thus, lead progressively in drug-seeking behaviors and relapsing disorders. No conflict of interest

The Covid-19 pandemic is a global threat to public health, mainly affecting vulnerable groups, such as the elderly, chronically ill patients, or patients with substance use disorders (SUD) [1] . Prolonged use results in neurobiological changes in the cerebral area, activating the "reward system," leading to development of drug-seeking behaviors and upregulating proinflammatory cytokines, as well as growth factors [ 2 , 3 ] . The immune system's response inducing Covid-19 virus even to moderate symptoms by adapting the immunomodulation, seems to lead to an inflammatory process, especially in patients with pre-existing production of inflammatory agents, such as patients with SUD [4] . Objective: The investigation of biopsychosocial responses of the Covid-19 pandemic in patients under medicationassisted treatment (MAT) with methadone and buprenorphine and their correlation to biological factors. Material and Methods: 64 patients with Covid-19 were included in the study sample, 26 (40.6%) under methadone administration and 38 (59.4%) under buprenorphine ones. The Control group consisted of patients with SUD that had not been infected by the virus and Covid-19 patients without previous history of substance use. Blood samples were obtained in both groups to determine C-reactive protein (CRP), cortisol, IFNa1, IFNa2, IFN γ , IL-1a, IL-1 β, IL-5, IL-6, IL-8, IL-10, IL-18, MCP-1, TNF-a, but in patients with Covid-19, blood samples were obtained at the first, seventh and sixteenth day after infection. The sample with SUD had completed a structured questionnaire (Medication-Assisted Treatment Questionnaire Covid-19 -MATQ/Covid-19) about Covid-19 effect in terms of medications' administration (methadone and buprenorphine) and psychosocial life. Statistical significance was ascertained by t-tests, ANOVA and Pearson's x 2 test as appropriate. Results: Reduced management of medications at take-home doses (p < 0.05) and physical dysfunctions (p < 0.05) were observed in both groups with SUD. Regarding the patients under methadone treatment, social isolation (p < 0.05) and the need for psychosocial support from the therapeutic programs (p < 0.001) were found increased. According to the results, the values of cortisol, IL-1a, IL-1b, IL-8 and MCP-1 were significantly elevated (p < 0.05) in the study sample compared to the control group. Furthermore, biological factors on the 7 th and 16 th day after Covid-19 infection (cortisol, IL-1b, IL-8, TNF-a, MCP-1, IL-6) in methadone administration were significantly increased (p < 0.05) while greater values of CRP (p < 0.05) on the first and seventh day were observed in the buprenorphine group. In respect of the findings, the IL-8 and MCP-1 were significantly increased in the methadone group compared to the buprenorphine group. Moreover, increased values of IL-8 and MCP-1 positively were correlated with the need for psychosocial support, drug-seeking behavior and relapse. Conclusions: In conclusion , the Covid-19 virus negatively influences the immune system in patients under substitution treatment. Although methadone and buprenorphine are key substances as MAT, they seem able to exacerbate the dysregulated cellular functions due to the Covid-19 virus and, thus, lead progressively in drug-seeking behaviors and relapsing disorders.

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Neurobiologic Advances from the Brain Disease Model of Addiction

Inflammatory response in heroin addicts undergoing methadone maintenance treatment

COVID-19: Immunology and treatment options

Association between childhood maltreatment and aggressive behavior in a sample of male prisoners: a cross-sectional study

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, Via F

Background: Many prisoners have complex pathology in which substance abuse and psychiatric disorders, together with medical illnesses, may play overlapping roles. In addition, aggressive behavior is a growing problem of concern to prison authorities [ 1 , 2 ] . To date, it has been suggested that a complex interplay between distal and proximal risk factors is likely to underlie aggression. Particularly, childhood trauma (CT) could be related to delinquency and adult violent criminal behavior [3] . Therefore, we aimed to investigate the prevalence of aggressive behavior among a S452